Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Pues a mi no me gusta mucho...
estos días deberia haber subido algo más si tuviera un producto con más espectativas.
Esto lo encontré ayer:
"For those who own Exelixis and wonder why the valuation is so miserable despite the great prostate cancer results, there is your answer. Management doesn’t understand the urology treatment paradigm and is listening to the wrong doctors.
Some reading this might object or scoff at the idea oncologists and urologists are at war with each other over patients. Scoff away, but I’m right. Eight years of AUA meetings, eight years of ASCO general meetings, and six years of ASCO prostate cancer meetings give me plenty of real and anecdotal information proving this battle rages constantly.
y luego por técnico, la media movil de los últimos 20 días no me gusta tampoco.
El RSI está neutro